• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于研究感染、发病机制、免疫和治疗方法的溃疡性皮肤利什曼病小鼠模型。

A Mouse Model of Ulcerative Cutaneous Leishmaniasis by to Investigate Infection, Pathogenesis, Immunity, and Therapeutics.

作者信息

Muñoz-Durango Natalia, Gómez Alexander, García-Valencia Natalia, Roldán Miguel, Ochoa Marcela, Bautista-Erazo David E, Ramírez-Pineda José R

机构信息

Grupo Inmunomodulación (GIM), Instituto de Investigaciones Médicas, Facultad de Medicina, Corporación Académica para el Estudio de Patologías Tropicales (CAEPT), Universidad de Antioquia, Medellín, Colombia.

Instituto de Patología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

出版信息

Front Microbiol. 2022 Jun 13;13:907631. doi: 10.3389/fmicb.2022.907631. eCollection 2022.

DOI:10.3389/fmicb.2022.907631
PMID:35770175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9234518/
Abstract

A mouse model of cutaneous leishmaniasis (CL) by that reproduces the characteristics of the human disease remains elusive. Here we report the development of a CL model that uses a mouse-adapted isolate to reproducibly induce a dermal disease with a remarkable similarity to human CL. BALB/c mice infected intradermally in the ear with 10 stationary UA-946 promastigotes develop a progressive cutaneous disease that exhibits the typical ulcerated lesions with indurated borders observed in CL patients. Although most of parasites in the inoculum die within the first week of infection, the survivors vigorously multiply at the infection site during the following weeks, paralleling disease appearance and aggravation. Regional lymphadenopathy as well as lymphatic dissemination of parasites to draining lymph nodes (dLN) was evidenced early after infection. Viable parasites were also isolated from spleen at later timepoints indicating systemic parasitic dissemination, but, strikingly, no signs of systemic disease were observed. Increasing numbers of myeloid cells and T lymphocytes producing IFNγ and IL-4 were observed in the dLN as disease progressed. A mixed adaptive -specific T cell-mediated response was induced, since recall experiments using dLN cells and splenocytes revealed the production of type 1 (IFNγ, IL-2), type 2 (IL-4, IL-13), regulatory (IL-10), and inflammatory (GM-CSF, IL-3) cytokines. Humoral adaptive response was characterized by early production of IgG1- followed by IgG2a-type of -specific antibodies. IFNγ/IL-4 and IgG2a/IgG1 ratios indicated that the initial non-protective Th2 response was redirected toward a protective Th1 response. studies revealed a profuse recruitment of myeloid cells and of IFNγ- and IL-4-producing T lymphocytes to the site of infection, and the typical histopathological changes induced by dermotropic species. Evidence that this model is suitable to investigate pharmacological and immunomodulatory interventions, as well as for antigen discovery and vaccine development, is also presented. Altogether, these results support the validity and utility of this novel mouse model to study the pathogenesis, immunity, and therapeutics of infections.

摘要

一种能够再现人类皮肤利什曼病(CL)特征的小鼠模型仍然难以捉摸。在此,我们报告了一种CL模型的建立,该模型使用一种适应小鼠的分离株,可重复性地诱导出一种与人类CL极为相似的皮肤疾病。用10个静止期的UA - 946前鞭毛体皮内注射感染耳部的BALB/c小鼠会发展出一种进行性皮肤疾病,表现出CL患者中观察到的典型的有硬结边缘的溃疡病变。尽管接种物中的大多数寄生虫在感染的第一周内死亡,但存活的寄生虫在接下来的几周内在感染部位大量繁殖,与疾病的出现和加重情况平行。感染后早期就证实了局部淋巴结病以及寄生虫向引流淋巴结(dLN)的淋巴扩散。在后期时间点,也从脾脏中分离出了活的寄生虫,表明存在全身寄生虫扩散,但令人惊讶的是,未观察到全身疾病的迹象。随着疾病进展,在dLN中观察到产生IFNγ和IL - 4的髓样细胞和T淋巴细胞数量增加。诱导了一种混合的适应性特异性T细胞介导的反应,因为使用dLN细胞和脾细胞的回忆实验显示产生了1型(IFNγ、IL - 2)、2型(IL - 4、IL - 13)、调节性(IL - 10)和炎性(GM - CSF、IL - 3)细胞因子。体液适应性反应的特征是早期产生IgG1,随后产生IgG2a型特异性抗体。IFNγ/IL - 4和IgG2a/IgG1比率表明最初的非保护性Th2反应转向了保护性Th1反应。研究揭示了髓样细胞以及产生IFNγ和IL - 4的T淋巴细胞大量募集到感染部位,以及嗜皮肤性物种诱导的典型组织病理学变化。还提供了证据表明该模型适用于研究药理和免疫调节干预措施,以及用于抗原发现和疫苗开发。总之,这些结果支持了这种新型小鼠模型在研究CL感染的发病机制、免疫和治疗方面的有效性和实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/668943154895/fmicb-13-907631-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/8780f582b164/fmicb-13-907631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/aa5b990008c7/fmicb-13-907631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/dfc0cf09c564/fmicb-13-907631-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/44176c5ed7d0/fmicb-13-907631-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/ad1b043a500c/fmicb-13-907631-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/b2a05888edbf/fmicb-13-907631-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/9741af1fb1f9/fmicb-13-907631-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/668943154895/fmicb-13-907631-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/8780f582b164/fmicb-13-907631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/aa5b990008c7/fmicb-13-907631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/dfc0cf09c564/fmicb-13-907631-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/44176c5ed7d0/fmicb-13-907631-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/ad1b043a500c/fmicb-13-907631-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/b2a05888edbf/fmicb-13-907631-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/9741af1fb1f9/fmicb-13-907631-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a51d/9234518/668943154895/fmicb-13-907631-g008.jpg

相似文献

1
A Mouse Model of Ulcerative Cutaneous Leishmaniasis by to Investigate Infection, Pathogenesis, Immunity, and Therapeutics.一种用于研究感染、发病机制、免疫和治疗方法的溃疡性皮肤利什曼病小鼠模型。
Front Microbiol. 2022 Jun 13;13:907631. doi: 10.3389/fmicb.2022.907631. eCollection 2022.
2
The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.调节性T细胞在巴拿马利什曼原虫(维氏亚属)感染中的免疫治疗作用。
J Immunol. 2014 Sep 15;193(6):2961-70. doi: 10.4049/jimmunol.1400728. Epub 2014 Aug 6.
3
Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.Toll样受体9配体CpG的局部递送可下调宿主免疫和炎症反应,改善已建立的巴拿马利什曼原虫(维氏亚属)慢性感染。
Infect Immun. 2017 Feb 23;85(3). doi: 10.1128/IAI.00981-16. Print 2017 Mar.
4
Dectin-1 Positive Dendritic Cells Expand after Infection with Parasites and Represent Promising Targets for Vaccine Development.寄生虫感染后,Dectin-1 阳性树突状细胞扩增,代表了疫苗开发的有前途的靶点。
Front Immunol. 2018 Feb 26;9:263. doi: 10.3389/fimmu.2018.00263. eCollection 2018.
5
Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.慢性 L.(Viannia)panamensis 感染的小鼠模型:IL-13 在疾病中的作用。
Eur J Immunol. 2010 Oct;40(10):2816-29. doi: 10.1002/eji.201040384.
6
Metastatic capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in golden hamsters.巴拿马利什曼原虫(维安尼亚亚属)和圭亚那利什曼原虫(维安尼亚亚属)在金黄仓鼠中的转移能力。
J Parasitol. 1991 Oct;77(5):762-8.
7
The F1F3 Recombinant Chimera of -Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Infection in Mice.-F 核苷酸水解酶 (NH36) 的 F1F3 重组嵌合体及其表位诱导小鼠对 感染产生交叉保护。
Front Immunol. 2019 Apr 9;10:724. doi: 10.3389/fimmu.2019.00724. eCollection 2019.
8
TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).TLR1/2 激活在异源初免-加强免疫接种(DNA-MVA)中增强 CD8+ T 细胞反应,提供针对利什曼原虫(Viannia)的保护。
PLoS Negl Trop Dis. 2011 Jun;5(6):e1204. doi: 10.1371/journal.pntd.0001204. Epub 2011 Jun 14.
9
Involvement of the Inflammasome and Th17 Cells in Skin Lesions of Human Cutaneous Leishmaniasis Caused by () .()引起的人类皮肤利什曼病皮肤损伤中的炎性小体和 Th17 细胞的参与
Mediators Inflamm. 2020 Oct 27;2020:9278931. doi: 10.1155/2020/9278931. eCollection 2020.
10
Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.Toll样受体2(TLR2)在体内控制皮肤利什曼病中发挥作用,但不需要被寄生虫脂磷壁酸激活。
Parasit Vectors. 2016 Oct 6;9(1):532. doi: 10.1186/s13071-016-1807-8.

引用本文的文献

1
Improving reproducibility and translational potential of mouse models: lessons from studying leishmaniasis.提高小鼠模型的可重复性和转化潜力:利什曼病研究的经验教训。
Front Immunol. 2025 Apr 22;16:1559907. doi: 10.3389/fimmu.2025.1559907. eCollection 2025.
2
The different impact of drug-resistant on the transcription programs activated in neutrophils.耐药性对中性粒细胞中激活的转录程序的不同影响。
iScience. 2024 Apr 18;27(5):109773. doi: 10.1016/j.isci.2024.109773. eCollection 2024 May 17.
3
Characterization of the Effect of -(2-Methoxyphenyl)-1-methyl-1-benzimidazol-2-amine, Compound 8, against and Its In Vivo Leishmanicidal Activity.

本文引用的文献

1
Protection and Pathology in Infection.感染中的保护与病理学
Pathogens. 2022 Apr 14;11(4):466. doi: 10.3390/pathogens11040466.
2
GM-CSF: Master regulator of the T cell-phagocyte interface during inflammation.GM-CSF:炎症过程中 T 细胞-吞噬细胞界面的主调控因子。
Semin Immunol. 2021 Apr;54:101518. doi: 10.1016/j.smim.2021.101518. Epub 2021 Nov 9.
3
Three decades of clinical trials on immunotherapy for human leishmaniases: a systematic review and meta-analysis.免疫疗法治疗人类利什曼病的 30 年临床试验:系统评价和荟萃分析。
-(2-甲氧基苯基)-1-甲基-1-苯并咪唑-2-胺(化合物 8)抗 和体内抗利什曼原虫活性的作用特征。
Int J Mol Sci. 2024 Jan 4;25(1):659. doi: 10.3390/ijms25010659.
4
Characterisation of 'Candidatus Methylobacter titanis' sp. nov., a putative novel species of Methylobacter clade 2 and their distribution in sediments of freshwater lakes in maritime Antarctica.描述“泰坦尼克甲基杆菌”的特性,这是一个假定的甲基杆菌 2 群的新物种,以及它们在南极洲沿海淡水湖沉积物中的分布。
Antonie Van Leeuwenhoek. 2023 Jul;116(7):721-738. doi: 10.1007/s10482-023-01840-1. Epub 2023 May 25.
5
Leishmanicidal and immunomodulatory properties of Brazilian green propolis extract (EPP-AF) and a gel formulation in a pre-clinical model.巴西绿蜂胶提取物(EPP-AF)及其凝胶制剂在临床前模型中的杀利什曼原虫和免疫调节特性。
Front Pharmacol. 2023 Feb 9;14:1013376. doi: 10.3389/fphar.2023.1013376. eCollection 2023.
Immunotherapy. 2021 Jun;13(8):693-721. doi: 10.2217/imt-2020-0184. Epub 2021 Apr 15.
4
Host-Directed Therapies for Cutaneous Leishmaniasis.针对皮肤利什曼病的宿主导向疗法。
Front Immunol. 2021 Mar 26;12:660183. doi: 10.3389/fimmu.2021.660183. eCollection 2021.
5
Involvement of the Inflammasome and Th17 Cells in Skin Lesions of Human Cutaneous Leishmaniasis Caused by () .()引起的人类皮肤利什曼病皮肤损伤中的炎性小体和 Th17 细胞的参与
Mediators Inflamm. 2020 Oct 27;2020:9278931. doi: 10.1155/2020/9278931. eCollection 2020.
6
In situ study of cellular immune response in human cutaneous lesions caused by Leishmania (Viannia) panamensis in Panama.在巴拿马,原位研究了导致人类皮肤病变的 Leishmania (Viannia) panamensis 引发的细胞免疫反应。
Parasite Immunol. 2021 Mar;43(3):e12801. doi: 10.1111/pim.12801. Epub 2020 Oct 29.
7
A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil.巴西一项评估米替福新与局部粒细胞巨噬细胞集落刺激因子治疗巴西利什曼原虫引起的皮肤利什曼病的双盲、随机试验。
Clin Infect Dis. 2021 Oct 5;73(7):e2465-e2469. doi: 10.1093/cid/ciaa1337.
8
Interventions for American cutaneous and mucocutaneous leishmaniasis.美国皮肤利什曼病和黏膜皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD004834. doi: 10.1002/14651858.CD004834.pub3.
9
TLR7 Sensing by Neutrophils Is Critical for the Control of Cutaneous Leishmaniasis.中性粒细胞 TLR7 感应对于控制皮肤利什曼病至关重要。
Cell Rep. 2020 Jun 9;31(10):107746. doi: 10.1016/j.celrep.2020.107746.
10
Development of a Mouse-Adapted MERS Coronavirus.一种适应小鼠的中东呼吸综合征冠状病毒的研制
Methods Mol Biol. 2020;2099:161-171. doi: 10.1007/978-1-0716-0211-9_13.